US regulatory status: approved. Mechanism: Osmotic laxative.
- Mechanism
- Osmotic laxative
pharma · Pancreatic Cancer Non-resectable
Shanghai Proton and
Shanghai Proton and Heavy Ion Center
Shanghai Proton and drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Shanghai Proton and pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Shanghai Proton and drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Shanghai Proton and in public FDA and regional records.